Works matching IS 14642662 AND DT 2002 AND VI 3 AND IP 2

Results: 11

The effect of ritonavir on saquinavir plasma concentration is independent of ritonavir dosage: combined analysis of pharmacokinetic data from 97 subjects.

Published in:

HIV Medicine, 2002, v. 3, n. 2, p. 97, doi. 10.1046/j.1468-1293.2002.00090.x

By:

Kilby, JM;
Hill, A;
Buss, N

Publication type:

Article

The impact of the M184V substitution in HIV-1 reverse transcriptase on treatment response.

Published in:

HIV Medicine, 2002, v. 3, n. 2, p. 135, doi. 10.1046/j.1468-1293.2002.00101.x

By:

Miller, V;
Stark, T;
Loeliger, AE;
Lange, JMA

Publication type:

Article

Switch studies: a review.

Published in:

HIV Medicine, 2002, v. 3, n. 2, p. 146, doi. 10.1046/j.1468-1293.2002.00102.x

By:

Murphy, RL;
Smith, WJ

Publication type:

Article

The changing demographics of new HIV diagnoses at a London centre from 1994 to 2000.

Published in:

HIV Medicine, 2002, v. 3, n. 2, p. 129, doi. 10.1046/j.1468-1293.2002.00103.x

By:

Barry, SM;
Lloyd-Owen, SJ;
Madge, SJ;
Cozzi-Lepri, A;
Evans, AJ;
Phillips, AN;
Johnson, MA

Publication type:

Article

HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/µL): an analysis of 338 clinical events from a randomized clinical trial*.

Published in:

HIV Medicine, 2002, v. 3, n. 2, p. 75, doi. 10.1046/j.1468-1293.2002.00104.x

By:

Floridia, M;
Fragola, V;
Galluzzo, CM;
Giannini, G;
Pirillo, MF;
Andreotti, M;
Tomino, C;
Vella for the ISS-IP1 Study Group, S

Publication type:

Article

Body composition changes in protease inhibitor-naive HIV-infected patients treated with two nucleoside reverse transcriptase inhibitors.

Published in:

HIV Medicine, 2002, v. 3, n. 2, p. 85, doi. 10.1046/j.1468-1293.2002.00105.x

By:

Tsekes, G;
Chrysos, G;
Douskas, G;
Paraskeva, D;
Mangafas, N;
Giannakopoulos, D;
Papanikolaou, M;
Georgiou, E;
Lazanas, MC

Publication type:

Article

Heterozygosity for CCR5-D Δ32 but notCCR2b-64I protects against certain intracellular pathogens.

Published in:

HIV Medicine, 2002, v. 3, n. 2, p. 91, doi. 10.1046/j.1468-1293.2002.00106.x

By:

Ashton, LJ;
Stewart, GJ;
Biti, R;
Law, M;
Cooper, DA;
Kaldor, JM

Publication type:

Article

Endogenous cytokine production protects T cells from spontaneous apoptosis during highly active antiretroviral therapy.

Published in:

HIV Medicine, 2002, v. 3, n. 2, p. 105, doi. 10.1046/j.1468-1293.2002.00107.x

By:

Ensoli, F;
Fiorelli, V;
De Cristofaro, M;
Collacchi, B;
Santini Muratori, D;
Alario, C;
Sacco, G;
Iebba, F;
Aiuti, F

Publication type:

Article

The relationship between ritonavir plasma trough concentration and virological and immunological response in HIV-infected children.

Published in:

HIV Medicine, 2002, v. 3, n. 2, p. 125, doi. 10.1046/j.1468-1293.2002.00108.x

By:

Gatti, G;
Pontali, E;
Boni, S;
De Pascalis, CR;
Bassetti, M;
Bassetti, D

Publication type:

Article

Impact of adherence on duration of virological suppression among patients receiving combination antiretroviral therapy.

Published in:

HIV Medicine, 2002, v. 3, n. 2, p. 118, doi. 10.1046/j.1468-1293.2002.00109.x

By:

Raboud, JM;
Harris, M;
Rae, S;
Montaner, JSG

Publication type:

Article

Table of Contents.

Published in:: 2002
Publication type:: Table of Contents